JOINT DRUG AGREEMENT

Major League Baseball's Joint Drug Prevention and Treatment Program

 

Major League Baseball's Joint Drug Prevention and Treatment Program (the "Program") was established by agreement of the Office of the Commissioner of Baseball and the Major League Baseball Players Association to: (i) educate Players on the risks associated with the use of Prohibited Substances; (ii) deter and end the use of Prohibitied Substances by Players; and (iii) provide for, in keeping with the overall purposes of the Program, an orderly, systematic, and cooperative resolution of any disputes that may arise concerning the existence, interpretation, or application of this Program.  Except as otherwise provided, any dispute arising under the Program shall be subject to resolution through the Grievance Procedure of the Basic Agreement.

The Program covers: (i) all Players on the Major League Clubs' 40-man rosters; (ii) any Player who becomes a free agent under Aritcle XIX or Articl XX of the Basic Agreement; and (iii) any Player who is released from a Major League roster unless the Player voluntarily retires or signs a Minor League contract with a club in an unaffiliated professional baseball league.

  • Twitter
  • Instagram
  • Facebook
  • YouTube
Players-Way-Logo1.jpg

© 2020 Major League Baseball Players Association (MLBPA). All Rights Reserved. The Diamond 9, Shield and MLB Players Choice logos shown below and the MLB PLAYERS, MAJOR LEAGUE BASEBALL PLAYERS ASSOCIATION, MLBPA, PLAYERS TRUST, PLAYERS CHOICE and INFIELD CHATTER marks are intellectual property owned by the MLBPA.  MLBPA trademarks, copyrighted works and other intellectual property rights are owned by MLBPA and may not be used without its consent.    

 

Contact the Major League Baseball Players Association for more information. Use of the Website signifies your agreement to the

Terms of Use and Privacy Policy.

logo.png